Progress and challenges of personalized neoantigens in the clinical treatment of tumors

Tumors are a serious threat to human health, and tumor treatments have continued to evolve from chemotherapy to targeted therapy, immunotherapy, and individualized immunotherapy. Tumor cells have many mutations that cause the production of neoantigens, which are unique to tumor cells. Tumor neoantig...

Full description

Bibliographic Details

Published in:	Medicine in Drug Discovery
Main Authors:	Hongyu Zhang, Xianchao Zhou, Dongliang Liu, Yufei Zhu, Qingyang Ma, Yuchao Zhang
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Subjects:	Tumor Neoantigen Peptides vaccinum
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590098620300178